Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.424
+0.024 (1.71%)
At close: Nov 6, 2026, 4:00 PM EST
1.410
-0.014 (-0.98%)
After-hours: Nov 6, 2026, 7:33 PM EST
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $6.37 million as of November 6, 2026. It is the 43,739th most valuable company in the world and the 5,809th biggest in the United States. Its market cap has increased by 69.85% in one year.
Market Cap
6.37M
Enterprise Value
-1.92M
1-Year Change
69.85%
Global Rank
Country Rank
#5,809 United States
Category
ChartMarket Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $6.37M, a decrease of -100.00%. That is a compound annual growth rate of -81.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 6.37M | 71.57% |
| Dec 31, 2025 | 3.71M | 1.92% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 7.26M |
| FibroBiologics | 6.81M |
| Alzamend Neuro | 6.80M |
| Aprea Therapeutics | 6.52M |
| Processa Pharmaceuticals | 6.47M |
| Ensysce Biosciences | 6.40M |
| Tempest Therapeutics | 6.30M |
| Exicure | 6.22M |